Dhiral Shah

Dhiral Shah has an extensive work experience in the scientific and pharmaceutical industry. Their most recent role is as a Senior Scientist II at Voyager Therapeutics, Inc. starting in October 2022. Prior to that, they worked as a Senior Scientist at TCR² Therapeutics Inc. from October 2021 to October 2022.

Dhiral also had a long tenure at Sanofi, where they held multiple positions. They started as a Process Engineer II in November 2011 and transitioned to the role of Scientist in September 2014. In September 2017, they were promoted to Senior Scientist, a position they held until October 2022.

Their educational background includes a PhD from Rensselaer Polytechnic Institute in New York, which they completed between August 2006 and July 2011.

Dhiral Shah completed their education in the field of Chemical Engineering. Dhiral obtained their Bachelor's degree (B. Chem. Eng.) from the Institute of Chemical Technology, Mumbai (formerly known as UDCT, Mumbai) from 2002 to 2006. After their undergraduate studies, they pursued their doctoral degree (PhD) at Rensselaer Polytechnic Institute from 2006 to 2011, specializing in Chemical Engineering. Additionally, in 2004, they attended the Indian Institute of Technology, Kanpur for a short duration, but no specific degree or field of study information is provided for this period.